Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Vanadium Nicotinate has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
Vanadyl nicotinate is a coordination salt of vanadium with nicotinic acid, so every dose delivers both ions. Someone already taking a separate niacin product is adding to that total. At the milligram amounts used in vanadium products the nicotinate contribution is small next to typical niacin dosing, but it is not zero. Anyone tracking niacin intake should count it.
Vanadium compounds inhibit protein tyrosine phosphatase 1B in laboratory systems, which prolongs insulin receptor signalling, while chromium is proposed to act on a separate step of the same pathway. Combining them is a formulation habit rather than a tested regimen. For anyone whose blood sugar is already being managed with medication, stacking two agents aimed at the same pathway needs medical oversight. The mechanistic overlap is in vitro work, not a demonstrated additive effect in people.
Vanadium moves between the plus five vanadate and plus four vanadyl oxidation states depending on the redox environment, and ascorbate pushes it toward vanadyl. The two states differ in how they are absorbed and in what they bind once inside. Taking vitamin C alongside a vanadium salt therefore alters the chemistry rather than simply adding to it. Which state is preferable is not settled.
Once absorbed, vanadium circulates largely bound to transferrin, the carrier that normally moves iron. High vanadium intake and iron status therefore interact at a shared binding protein. This is a reason to keep the two apart in a stack rather than a benefit. The competition is documented in binding chemistry, not quantified as a nutritional deficit in people at supplement doses.
The vanadate ion has almost the same geometry and charge distribution as phosphate, which is exactly why it inhibits phosphatases and ATPases. That mimicry is the source of both its laboratory usefulness and its toxicity ceiling. It is not a nutrient partnership, it is a reason vanadium has a narrow intake range. The chemistry is textbook.
Dithiol compounds reduce vanadate and can chelate the resulting vanadyl ion, which changes tissue distribution. Formulas that combine the two are relying on a mechanistic story rather than combination trials. The direction of the net effect is not established. Read it as an open question rather than a designed pairing.
Nothing specific on file for Vanadium Nicotinate. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.